Metabolic dysfunction-associated steatotic liver disease (MASLD)—previously known as "non-alcoholic fatty liver ...

Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a new study.

The findings are significant for the liver research community and others interested in the gut-liver axis. (A) AOAH cleaves the two piggyback fatty acyl chains from the lipid A moiety, inactivating ...

As one in three Indians gets diagnosed with non-alcoholic fatty liver, a look at how lifestyle choices can make a difference.

June 14, 2024 — Fatty liver disease ... Find an Effective Treatment Jan. 23, 2024 — Metabolic dysfunction--associated steatohepatitis or MASH (formerly known as nonalcoholic steatohepatitis ...

No. Antiviral treatment is the best approach for hep C. But you can complement your treatment with approaches like diet and ...

Positive results from the MAESTRO-NASH OUTCOMES study could make resmetirom the first medication approved for patients with compensated NASH ...

The treatment of metabolic dysfunction-associated steatohepatitis (MASH) has proven challenging, with many compounds failing during development for various reasons. However, with the recent ...

The prevalence rates of metabolic dysfunction–associated steatohepatitis (MASH) and metabolic dysfunction–associated ...

This breakthrough provides an opportunity for the development of new treatments to tackle cardiovascular disease and prevent the progression of fatty liver disease. Lead researcher Dr. Laeticia ...

Inventiva SA (NASDAQ:IVA) stock traded higher on Monday, with a strong session volume of 8.55 million compared to an average ...